Skip to main content
. 2018 Jun 19;6:58. doi: 10.1186/s40425-018-0357-3

Table 1.

Tumor genomic next generation sequencing (NGS) study reveals mutations in several genes, including somatic mutations in genes mutated in the sebaceous carcinoma COSMIC dataset (in bold)

Gene Alteration Subcellular localization Pathway
LRP1B G3156C, Q1125* Plasma membrane Receptor mediated endocytosis
CCND1 S41L Nucleus; cytosol Cyclin D1, cell cycle
TET2 P174H Nucleoplasm DNA demethylation
TP53 rearrangement, del exon 10-11 Nucleoplasm DNA repair
FANCA A816V, R685S Nucleus DNA repair
FGF6 A63T Extracellular Growth factor
MYST3 Q1681_Q1684del Nucleolus; cytosol Histone acetyltransferase (HAT)
KRAS G12C Cytosol MAPK signalling
RBM10 F173fs*7 Nucleus mRNA splicing
MET amplification Plasma membrane Receptor tyrosine kinase
FGFR3 I539del Endoplasmic reticulum Receptor tyrosine kinase
FLT4 K520E, R658W Nucleus; plasma membrane Receptor tyrosine kinase
ROS1 N692H Vesicles Receptor tyrosine kinase
TERT -124C>T Nucleoplasm Telomerase
WT1 R471S Nucleoplasm WT1 Transcription Factor
MYC L435F Nucleoplasm MYC Transcription Factor
ZNF703 G406R Nucleus Transcriptional co-repressor
c11orf30 C1211S Nucleoplasm Trascriptional Repressor
FLCN R320Q Nucleus; cytosol Tumor suppressor
TNFAIP3 R706Q Cytosol Ubiquitination

*denotes mutations causing a premature stop codon

fs denotes the presence of a frameshift mutation